Pasar al contenido principal

PAPEL ANCESTRAL DE LOS JASMONATOS EN TERMOTOLERANCIA

PID2019-107012RB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2019
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

AI is a viable alternative to high throughput screening: a 318-target study

  • Chini, Andrea
  • Santiago, César
  • Rodríguez-Frade, José Miguel
  • Mellado, Mario
  • Solano, Roberto
  • García-Cuesta, Eva María
  • Atomwise AIMS Program
High throughput screening (HTS) is routinely used to identify bioactive small molecules. This requires physical compounds, which limits coverage of accessible chemical space. Computational approaches combined with vast on-demand chemical libraries can access far greater chemical space, provided that the predictive accuracy is sufficient to identify useful molecules. Through the largest and most diverse virtual HTS campaign reported to date, comprising 318 individual projects, we demonstrate that our AtomNet® convolutional neural network successfully finds novel hits across every major therapeutic area and protein class. We address historical limitations of computational screening by demonstrating success for target proteins without known binders, high-quality X-ray crystal structures, or manual cherry-picking of compounds. We show that the molecules selected by the AtomNet® model are novel drug-like scaffolds rather than minor modifications to known bioactive compounds. Our empirical results suggest that computational methods can substantially replace HTS as the first step of small-molecule drug discovery., PID2019-107012RB-100 (MICINN/FEDER) and AEI/10.13039/501100011033, "Severo Ochoa" Programme for Centres of Excellence in R&D (SEV-2017-0712). PID2020-114980RB-I00. PID2019-107012RB-100 (MICINN/FEDER) and AEI/10.13039/501100011033, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Evolution of the jasmonate ligands and their biosynthetic pathways

  • Chini, Andrea
  • Monte, Isabel
  • Zamarreño, Angel M.
  • García-Mina, José María
  • Solano, Roberto
Different plant species employ different jasmonates to activate a conserved signalling pathway in land plants, where (+)-7-iso-JA-Ile (JA-Ile) is the ligand for the COI1/JAZ receptor in angiosperms and dn-cis-OPDA, dn-iso-OPDA and Δ4 -dn-iso-OPDA act as ligands in Marchantia polymorpha. In addition, some jasmonates play a COI1-independent role. To understand the distribution of bioactive jasmonates in the green lineage and how their biosynthetic pathways evolved, we performed phylogenetic analyses and systematic jasmonates profiling in representative species from different lineages. We found that both OPDA and dn-OPDA are ubiquitous in all tested land plants and present also in charophyte algae, underscoring their importance as ancestral signalling molecules. By contrast, JA-Ile biosynthesis emerged within lycophytes coincident with the evolutionary appearance of JAR1 function. We identified that the OPR3-independent JA biosynthesis pathway is ancient and predates the evolutionary appearance of the OPR3-dependent pathway. Moreover, we identified a negative correlation between dn-iso-OPDA and JA-Ile in land plants, which supports that in bryophytes and lycophytes dn-iso-OPDA represents the analogous hormone to JA-Ile in other vascular plants., This research was funded by the Spanish Ministry for Science and Innovation grant PID2019-107012RB-100 and ‘Severo Ochoa’ Programme for Centres of Excellence SEV-2017-0712 funded by the MCIN/AEI/10.13039/501100011033., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

A Reactive Antagonist Strategy: Cysteine-Directed Covalent Molecular Glue in Plant Hormone Receptor Regulation

  • Ueda, Minoru
  • Matsumoto, Kotaro
  • Nomura, Takao
  • Takaoka, Yousuke
  • Okumura, Taichi
  • Kozaki, Wataru
  • Hoshikawa, Hikaru
  • Nishizato, Yuho
  • Chini, Andrea
  • Solano, Roberto
  • Maenaka, Katsumi
Controlling protein-protein interactions (PPIs) remains a challenge in modern chemistry. In plants, jasmonoyl-L-isoleucine (JA-Ile) acts as a molecular glue that facilitates PPIs between the F-box protein COI1 and JAZ repressors, leading to transcriptional reprogramming. However, the functional redundancy of JAZ proteins complicates biological studies. To overcome this, we introduce a reactive antagonist (RA) strategy that selectively induces COI1-JAZ interactions for a Cys-mutated JAZ mutant while inhibiting interactions with wild-type JAZs. We designed and synthesized COR-oxime derivatives, identifying O-bromo-ethyl COR-oxime as an optimal RA, functioning as a Cys-directed covalent molecular glue. Mass spectrometry and fluorescence anisotropy assays confirmed its selective covalent binding to Cys-mutated JAZ1, leading to targeted degradation in Arabidopsis. This strategy enables precise functional dissection of JAZ subtypes without affecting endogenous pathways. Given the genetic redundancy in many biological systems, the RA strategy provides a powerful chemical biology tool for dissecting complex signaling networks beyond plant hormone research., This work was financially supported by Grants-in-Aid for Scientific Research from Japan Society for the Promotion of Science (JSPS), Japan (Nos. 23H00316, 23K17967, 22KK0076, 21K19037, 20H00402, JPJSBP120229905, and JPJSBP120239903 to MU) and a Grant-in-Aid for Transformative Research Areas (A) “Latent Chemical Space” [JP23H04880 and JP23H04883] for MU from the Ministry of Education, Culture, Sports, Science and Technology, Japan. This research was also supported by Discovery (Basis for Supporting Innovative Drug Discovery and Life Science Research (BINDS)) from AMED under Grant Number JP25ama121037 to KM, and PID2019-107012RB-100 funded by MICIU/AEI/10.13039/501100011033 and EU/FEDER to RT and AC, and Grant CEX2023-001386-S funded by MICIU/AEI/ 10.13039/501100011033., Peer reviewed, Sin uso de modelos vivos